| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 提供委托加工服务(元) | 94,373,700.00 | 155,404,419.75 | 98,695,600.00 | - | 69,109,500.00 |
| 销售商品(元) | 409,831,200.00 | 911,510,531.84 | 483,056,200.00 | - | 519,871,900.00 |
| 销售原料(元) | - | - | - | - | 135,900.00 |
| 租赁收入(元) | - | 18,800,870.48 | - | - | 7,168,300.00 |
| CDMO业务(元) | - | - | - | 121,669,600.00 | - |
| 授权许可(元) | - | 3,113,087,093.11 | 51,000,000.00 | 66,110,000.00 | - |
| 医药制造(元) | - | - | - | 990,903,700.00 | - |
| 租赁服务(元) | 7,411,600.00 | - | 9,261,600.00 | - | - |
| 授予知识产权许可(元) | 351,827,700.00 | - | - | - | - |
| 其他服务(元) | - | 315,450.47 | - | - | 334,100.00 |
| 其他(元) | 2,259,000.00 | - | - | - | - |
| 营业成本(元) | |||||
| 提供委托加工服务(元) | 62,589,200.00 | 101,611,705.88 | 69,926,200.00 | - | 58,903,500.00 |
| 销售商品(元) | 98,536,800.00 | 220,708,897.46 | 116,209,800.00 | - | 96,153,600.00 |
| 销售原料(元) | - | - | - | - | 135,900.00 |
| 租赁收入(元) | - | 10,603,087.08 | - | - | 3,921,800.00 |
| CDMO业务(元) | - | - | - | 98,903,700.00 | - |
| 授权许可(元) | - | - | - | - | - |
| 医药制造(元) | - | - | - | 197,644,000.00 | - |
| 租赁服务(元) | 4,046,900.00 | - | 5,192,600.00 | - | - |
| 授予知识产权许可(元) | 2,990,000.00 | - | - | - | - |
| 其他服务(元) | - | 28,800.00 | - | - | - |
| 其他(元) | 816,200.00 | - | - | - | - |
| 毛利(元) | |||||
| 提供委托加工服务(元) | 31,784,500.00 | 53,792,713.87 | 28,769,400.00 | - | 10,206,000.00 |
| 销售商品(元) | 311,294,400.00 | 690,801,634.38 | 366,846,400.00 | - | 423,718,300.00 |
| 销售原料(元) | - | - | - | - | - |
| 租赁收入(元) | - | 8,197,783.40 | - | - | 3,246,500.00 |
| CDMO业务(元) | - | - | - | 22,765,900.00 | - |
| 授权许可(元) | - | - | 51,000,000.00 | 66,110,000.00 | - |
| 医药制造(元) | - | - | - | 793,259,700.00 | - |
| 租赁服务(元) | 3,364,700.00 | - | 4,069,000.00 | - | - |
| 授予知识产权许可(元) | 348,837,700.00 | - | - | - | - |
| 其他服务(元) | - | 286,650.47 | - | - | 334,100.00 |
| 其他(元) | 1,442,800.00 | - | - | - | - |
| 毛利率(%) | |||||
| 提供委托加工服务(%) | 33.68 | 34.61 | 29.15 | - | 14.77 |
| 销售商品(%) | 75.96 | 75.79 | 75.94 | - | 81.50 |
| 销售原料(%) | - | - | - | - | - |
| 租赁收入(%) | - | 43.60 | - | - | 45.29 |
| CDMO业务(%) | - | - | - | 18.71 | - |
| 授权许可(%) | - | - | - | - | - |
| 医药制造(%) | - | - | - | 80.05 | - |
| 租赁服务(%) | 45.40 | - | 43.93 | - | - |
| 授予知识产权许可(%) | 99.15 | - | - | - | - |
| 其他服务(%) | - | 90.87 | - | - | - |
| 其他(%) | 63.87 | - | - | - | - |
| 收入构成(%) | |||||
| 提供委托加工服务(%) | 10.90 | 3.70 | 15.37 | - | 11.58 |
| 销售商品(%) | 47.34 | 21.71 | 75.24 | - | 87.14 |
| 销售原料(%) | - | - | - | - | 0.02 |
| 租赁收入(%) | - | 0.45 | - | - | 1.20 |
| CDMO业务(%) | - | - | - | 10.32 | - |
| 授权许可(%) | - | 74.14 | 7.94 | 5.61 | - |
| 医药制造(%) | - | - | - | 84.07 | - |
| 租赁服务(%) | 0.86 | - | 1.44 | - | - |
| 授予知识产权许可(%) | 40.64 | - | - | - | - |
| 其他服务(%) | - | 0.01 | - | - | 0.06 |
| 其他(%) | 0.26 | - | - | - | - |
| 毛利构成(%) | |||||
| 提供委托加工服务(%) | 4.56 | 7.14 | 6.38 | - | 2.33 |
| 销售商品(%) | 44.68 | 91.73 | 81.40 | - | 96.85 |
| 销售原料(%) | - | - | - | - | 0.00 |
| 租赁收入(%) | - | 1.09 | - | - | 0.74 |
| CDMO业务(%) | - | - | - | 2.58 | - |
| 授权许可(%) | - | 0.00 | 11.32 | 7.49 | - |
| 医药制造(%) | - | - | - | 89.92 | - |
| 租赁服务(%) | 0.48 | - | 0.90 | - | - |
| 授予知识产权许可(%) | 50.07 | - | - | - | - |
| 其他服务(%) | - | 0.04 | - | - | 0.08 |
| 其他(%) | 0.21 | - | - | - | - |